Compounds and compositions for the treatment of neurodegenerative and inflammatory diseases
US11541023B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 13, 2019 |
| Grant date | Jan 3, 2023 |
| Priority date | — |
| Expiry date | Aug 29, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C235/66
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds exhibiting kallikrein inhibitory activity, and to compositions comprising at least one of these compounds for use in the treatment of diseases or disorders in which kallikrein activity is dysregulated, particularly neurodegenerative and inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.